Sanofi
SNY
44,95 €
Share price
-2.26%
Change (1 day)
3.54%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Revenue for Sanofi (SNY)
Revenue in 2024 (TTM): €44.28 Billion
According to Sanofi's latest financial reports the company's current revenue (TTM 
) is €42.55 Billion. a decrease over the revenue in the year 2023 that were of €46.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sanofi from 2003 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €44.28 B | -4.65% |
| 2023 | €46.44 B | 2.32% |
| 2022 | €45.38 B | 15.86% |
| 2021 | €39.17 B | |
| 2019 | €37.63 B | 5.48% |
| 2018 | €35.67 B | -1.46% |
| 2017 | €36.20 B | 4.31% |
| 2016 | €34.70 B | 3.63% |
| 2015 | €33.49 B | -1.81% |
| 2014 | €34.10 B | 2.41% |
| 2013 | €33.30 B | -7.37% |
| 2012 | €35.95 B | 2.56% |
| 2011 | €35.05 B | 9.44% |
| 2010 | €32.03 B | 4.18% |
| 2009 | €30.74 B | 6.69% |
| 2008 | €28.81 B | -2.37% |
| 2007 | €29.51 B | 0.05% |
| 2006 | €29.50 B | 4.18% |
| 2005 | €28.32 B | 85.8% |
| 2004 | €15.24 B | 88.61% |
| 2003 | €8.08 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €56.92 B | 33.79% | 🇺🇸 USA |
 | €56.44 B | 32.66% | 🇺🇸 USA |
 | €42.85 B | 0.71% | 🇺🇸 USA |
 | €45.88 B | 7.84% | 🇨🇭 Switzerland |
 | €35.64 B | -16.22% | 🇬🇧 UK |
 | €14.67 B | -65.51% | 🇮🇱 Israel |
 | €78.80 B | 85.20% | 🇺🇸 USA |
 | €39.96 B | -6.08% | 🇺🇸 USA |
 | €37.16 B | -12.65% | 🇩🇰 Denmark |
 | €37.21 B | -12.53% | 🇺🇸 USA |